CLASS II ONGOING Device recall · Reported 15 Oct 2025 · FDA Enforcement Report

ClariTEE Miniaturized TEE probe recalled by ImaCor

ImaCor is recalling ClariTEE Miniaturized TEE probe, distributed nationwide in the US. The recall was initiated on 29 Aug 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesModel CLT-010; UDI-DI 00861589000108; Lot number: 20261209.
Quantity recalled45 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0038-2026
FDA event ID
97505
Recalling firm
ImaCor, Jericho, NY
Classification
Class II
Status
Ongoing
Recall initiated
29 Aug 2025
FDA classified
3 Oct 2025
Reported
15 Oct 2025
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

29 Aug 2025Recall initiated by company
3 Oct 2025Classified by FDA+35 days
15 Oct 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Production assembly error resulting in the potential for reversed articulation, where moving the lever forward caused the probe tip to anteflex rather than retroflex, and vice versa.

Product as listed by the FDA

ClariTEE Miniaturized TEE probe. Model Number: CLT-010. Ultrasound miniaturized TEE probe for use with Mobile Ultrasound, ImaCor model ZHH.

Where it was distributed

US Nationwide distribution in the states of South Carolina, New Jersey, Pennsylvania, Florida, and Georgia.

Nationwide FloridaGeorgiaNew JerseyPennsylvaniaSouth Carolina

Questions about this recall

Why was it recalled?

Production assembly error resulting in the potential for reversed articulation, where moving the lever forward caused the probe tip to anteflex rather than retroflex, and vice versa.

Which lots are affected?

Model CLT-010; UDI-DI 00861589000108; Lot number: 20261209.

Where was it sold?

US Nationwide distribution in the states of South Carolina, New Jersey, Pennsylvania, Florida, and Georgia.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from ImaCor

All 2
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IIClariTEE Probe- Miniature transesophageal echo ultrasound recalledImaCorPackaging Defects4 states

Other Imaging Equipment recalls

All 2,350